Management of toxicities of BRAF inhibitors and MEK inhibitors in advanced melanoma

Sibaud, V; Baric, L; Cantagrel, A; Di Palma, M; Ederhy, S; Paques, M; Perlemuter, G

Sibaud, V (corresponding author), Inst Univ Canc Toulouse Oncopole, Dept Oncol Med & Oncodermatol, Toulouse, France.

BULLETIN DU CANCER, 2021; 108 (5): 528

Abstract

Major therapeutic advances have been made recently in the treatment of metastatic melanoma, due to the development of targeted therapies, namely BRAF ......

Full Text Link